Ward E, Dawkins L, Holland R, Pope I, Notley C
University of East Anglia, Norwich Research Park, Norwich NR4 7TJ, UK.
London South Bank University, London, UK.
Perspect Public Health. 2023 Aug 6:17579139231185481. doi: 10.1177/17579139231185481.
BACKGROUND: In the UK, most smokers choosing e-cigarettes to quit smoking will access vaping via commercial routes. In recent years, however, a shift towards medicalisation of vaping has become apparent, with public health guidance supporting e-cigarettes for smoking cessation and increased partnership working between healthcare professionals and the vaping industry. To achieve the UK's Smokefree 2030 target, the UK Government has set out measures to use e-cigarettes in National Health Service (NHS) settings and to move towards streamlining processes to make e-cigarettes available to a million smokers. This article aims to understand acceptability of different approaches by seeking perspectives of people with lived experience of e-cigarette use for smoking cessation. METHODS: Mixed methods data collected between March 2018 and March 2019 as part of a broader study of e-cigarette use trajectories (ECtra study). Data here relate to the views of partnership working and medicalisation of vaping extracted from 136 interviews/extended surveys of people who had used e-cigarettes to try to stop smoking. Qualitative data were thematically analysed. Participant ratings of interventions were presented descriptively, and differences in participant characteristics and ratings were reported. RESULTS: Three qualitative themes were identified: pro-partnership, anti-partnership and medicalisation dissonance. Medicalisation was discussed for its potential to reassure smokers about e-cigarette harms and its potential to reach smokers from disadvantaged backgrounds. Concerns were raised about cost-effectiveness, quality of support, conflicts of interest and limiting product choice. Most participants rated interventions involving partnership working as potentially helpful in switching from smoking to vaping. There were no statistically significant associations between age, gender and socioeconomic status, and helpfulness ratings. CONCLUSION: Both commercial and medical routes to vaping offer perceived benefits to vapers and may complement and reinforce each other to support smoking cessation.
背景:在英国,大多数选择电子烟戒烟的吸烟者会通过商业途径获取电子烟产品。然而,近年来,电子烟的医疗化趋势日益明显,公共卫生指南支持使用电子烟戒烟,医疗保健专业人员与电子烟行业之间的合作也有所增加。为实现英国2030年无烟目标,英国政府已制定措施,在国民医疗服务体系(NHS)中使用电子烟,并简化流程,以使100万吸烟者能够获得电子烟。本文旨在通过寻求有使用电子烟戒烟亲身经历者的观点,了解不同方法的可接受性。 方法:2018年3月至2019年3月期间收集的混合方法数据,作为电子烟使用轨迹更广泛研究(ECtra研究)的一部分。这里的数据涉及从136名使用电子烟试图戒烟者的访谈/扩展调查中提取的关于电子烟合作及医疗化的观点。对定性数据进行了主题分析。对干预措施的参与者评分进行了描述性呈现,并报告了参与者特征和评分的差异。 结果:确定了三个定性主题:支持合作、反对合作和医疗化失调。讨论了医疗化在让吸烟者放心电子烟危害方面的潜力,以及其覆盖弱势群体吸烟者的潜力。人们对成本效益、支持质量、利益冲突和产品选择受限表示担忧。大多数参与者认为涉及合作的干预措施可能有助于从吸烟转向使用电子烟。年龄、性别和社会经济地位与有益性评分之间没有统计学上的显著关联。 结论:电子烟的商业和医疗途径对电子烟使用者都有明显益处,可能相互补充和加强,以支持戒烟。
Perspect Public Health. 2023-8-6
J Med Internet Res. 2025-7-3
Nicotine Tob Res. 2024-9-23